Logo image of BNFT

BENEFITFOCUS INC (BNFT) Stock Fundamental Analysis

NASDAQ:BNFT - Nasdaq - US08180D1063 - Common Stock - Currency: USD

10.5  +0.01 (+0.1%)

After market: 10.5 0 (0%)

Fundamental Rating

2

BNFT gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 283 industry peers in the Software industry. BNFT has a bad profitability rating. Also its financial health evaluation is rather negative. BNFT has a decent growth rate and is not valued too expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

1

1. Profitability

1.1 Basic Checks

In the past year BNFT was profitable.
In the past year BNFT had a positive cash flow from operations.
BNFT Yearly Net Income VS EBIT VS OCF VS FCFBNFT Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 0 20M -20M -40M -60M

1.2 Ratios

BNFT has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BNFT Yearly ROA, ROE, ROICBNFT Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 0 500 -500 -1K

1.3 Margins

BNFT has a worse Gross Margin (50.35%) than 69.10% of its industry peers.
BNFT's Gross Margin has improved in the last couple of years.
The Profit Margin and Operating Margin are not available for BNFT so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 50.35%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.18%
GM growth 5Y2.2%
BNFT Yearly Profit, Operating, Gross MarginsBNFT Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 0 20 -20 40

More info and screens

2

2. Health

2.1 Basic Checks

BNFT does not have a ROIC to compare to the WACC, probably because it is not profitable.
BNFT has more shares outstanding than it did 1 year ago.
The debt/assets ratio for BNFT has been reduced compared to a year ago.
BNFT Yearly Shares OutstandingBNFT Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 10M 20M 30M
BNFT Yearly Total Debt VS Total AssetsBNFT Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 100M 200M 300M

2.2 Solvency

BNFT has an Altman-Z score of -0.99. This is a bad value and indicates that BNFT is not financially healthy and even has some risk of bankruptcy.
BNFT has a Altman-Z score of -0.99. This is amonst the worse of the industry: BNFT underperforms 80.07% of its industry peers.
BNFT has a debt to FCF ratio of 65.75. This is a negative value and a sign of low solvency as BNFT would need 65.75 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 65.75, BNFT is in line with its industry, outperforming 59.80% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 65.75
Altman-Z -0.99
ROIC/WACCN/A
WACC10.98%
BNFT Yearly LT Debt VS Equity VS FCFBNFT Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 0 100M 200M

2.3 Liquidity

BNFT has a Current Ratio of 1.42. This is a normal value and indicates that BNFT is financially healthy and should not expect problems in meeting its short term obligations.
BNFT has a worse Current ratio (1.42) than 60.13% of its industry peers.
A Quick Ratio of 1.42 indicates that BNFT should not have too much problems paying its short term obligations.
The Quick ratio of BNFT (1.42) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.42
Quick Ratio 1.42
BNFT Yearly Current Assets VS Current LiabilitesBNFT Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 50M 100M 150M 200M

More info and screens

4

3. Growth

3.1 Past

BNFT shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 116.67%, which is quite impressive.
The Revenue has decreased by -5.72% in the past year.
Measured over the past years, BNFT shows a small growth in Revenue. The Revenue has been growing by 2.15% on average per year.
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y0.56%
Revenue growth 5Y2.15%
Sales Q2Q%-9.41%

3.2 Future

BNFT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 117.19% yearly.
Based on estimates for the next years, BNFT will show a small growth in Revenue. The Revenue will grow by 0.93% on average per year.
EPS Next Y180.75%
EPS Next 2Y105.18%
EPS Next 3Y117.19%
EPS Next 5YN/A
Revenue Next Year-2.12%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.93%
Revenue Next 5YN/A

3.3 Evolution

The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
BNFT Yearly Revenue VS EstimatesBNFT Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M
BNFT Yearly EPS VS EstimatesBNFT Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -1 -2

More info and screens

4

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings ratio is 350.00, which means the current valuation is very expensive for BNFT.
The rest of the industry has a similar Price/Earnings ratio as BNFT.
Compared to an average S&P500 Price/Earnings ratio of 26.60, BNFT is valued quite expensively.
The Price/Forward Earnings ratio is 39.59, which means the current valuation is very expensive for BNFT.
Based on the Price/Forward Earnings ratio, BNFT is valued a bit cheaper than 71.43% of the companies in the same industry.
BNFT is valuated expensively when we compare the Price/Forward Earnings ratio to 22.43, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 350
Fwd PE 39.59
BNFT Price Earnings VS Forward Price EarningsBNFT Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300

4.2 Price Multiples

BNFT's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. BNFT is cheaper than 81.40% of the companies in the same industry.
BNFT's Price/Free Cash Flow ratio is a bit cheaper when compared to the industry. BNFT is cheaper than 63.79% of the companies in the same industry.
Industry RankSector Rank
P/FCF 202.47
EV/EBITDA 23.2
BNFT Per share dataBNFT EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 -2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
BNFT's earnings are expected to grow with 117.19% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.94
PEG (5Y)N/A
EPS Next 2Y105.18%
EPS Next 3Y117.19%

More info and screens

0

5. Dividend

5.1 Amount

BNFT does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

BENEFITFOCUS INC

NASDAQ:BNFT (1/23/2023, 8:12:24 PM)

After market: 10.5 0 (0%)

10.5

+0.01 (+0.1%)

Chartmill FA Rating
GICS SectorInformation Technology
GICS IndustryGroupSoftware & Services
GICS IndustrySoftware
Earnings (Last)11-07 2022-11-07/amc
Earnings (Next)02-27 2023-02-27/amc
Inst OwnersN/A
Inst Owner ChangeN/A
Ins Owners24.24%
Ins Owner Change0%
Market Cap361.42M
Analysts47.5
Price Target10.71 (2%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly DividendN/A
Dividend Growth(5Y)N/A
DP-25.78%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)27.67%
Min EPS beat(2)17.92%
Max EPS beat(2)37.42%
EPS beat(4)4
Avg EPS beat(4)104.4%
Min EPS beat(4)17.92%
Max EPS beat(4)252.92%
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)0
Avg Revenue beat(2)-1.79%
Min Revenue beat(2)-1.87%
Max Revenue beat(2)-1.7%
Revenue beat(4)1
Avg Revenue beat(4)0.11%
Min Revenue beat(4)-1.87%
Max Revenue beat(4)5.18%
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)31.25%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-3.23%
EPS NY rev (1m)0%
EPS NY rev (3m)-33.72%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE 350
Fwd PE 39.59
P/S 1.45
P/FCF 202.47
P/OCF 29.57
P/B N/A
P/tB N/A
EV/EBITDA 23.2
EPS(TTM)0.03
EY0.29%
EPS(NY)0.27
Fwd EY2.53%
FCF(TTM)0.05
FCFY0.49%
OCF(TTM)0.36
OCFY3.38%
SpS7.24
BVpS-0.72
TBVpS-2.24
PEG (NY)1.94
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 50.35%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexcg growth 3YN/A
ROICexcg growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y2.18%
GM growth 5Y2.2%
F-Score3
Asset Turnover1.07
Health
Industry RankSector Rank
Debt/Equity N/A
Debt/FCF 65.75
Debt/EBITDA 6.43
Cap/Depr 39.3%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.42
Quick Ratio 1.42
Altman-Z -0.99
F-Score3
WACC10.98%
ROIC/WACCN/A
Cap/Depr(3y)52.55%
Cap/Depr(5y)52.42%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)116.67%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%36.84%
EPS Next Y180.75%
EPS Next 2Y105.18%
EPS Next 3Y117.19%
EPS Next 5YN/A
Revenue 1Y (TTM)-5.72%
Revenue growth 3Y0.56%
Revenue growth 5Y2.15%
Sales Q2Q%-9.41%
Revenue Next Year-2.12%
Revenue Next 2Y-0.22%
Revenue Next 3Y0.93%
Revenue Next 5YN/A
EBIT growth 1Y-246.91%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year589.49%
EBIT Next 3Y111.48%
EBIT Next 5YN/A
FCF growth 1Y-53.27%
FCF growth 3Y215.77%
FCF growth 5YN/A
OCF growth 1Y-24.6%
OCF growth 3Y55.1%
OCF growth 5YN/A